Tscan Therapeutics Inc
(TCRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 242,159 | 140,513 | 133,359 | 155,193 | 208,842 |
| Marketable Securities | 55,517 | 22,270 | 58,685 | 60,230 | N/A |
| Receivables | N/A | N/A | N/A | N/A | 31,926 |
| TOTAL | $299,530 | $164,721 | $194,237 | $217,567 | $242,218 |
| Non-Current Assets | |||||
| PPE Net | 7,615 | 7,201 | 7,742 | 8,595 | 8,206 |
| Investments And Advances | 1,746 | 1,647 | 1,647 | 1,647 | 1,647 |
| Other Non-Current Assets | 65,980 | 67,263 | 68,523 | 63,570 | 64,852 |
| TOTAL | $75,341 | $76,111 | $77,912 | $73,812 | $74,705 |
| Total Assets | $374,871 | $240,832 | $272,149 | $291,379 | $316,923 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 10,336 | 6,797 | 3,347 | 1,110 | N/A |
| Accounts payable and accrued liabilities | 3,110 | 2,123 | 2,374 | 3,196 | 3,394 |
| Accrued Expenses | 10,808 | 8,786 | 10,716 | 9,257 | 8,304 |
| TOTAL | $38,572 | $31,479 | $29,820 | $33,151 | $35,118 |
| Non-Current Liabilities | |||||
| Long Term Debt | 20,112 | 23,449 | 26,700 | 28,835 | 29,722 |
| Deferred Revenues | 10,704 | 10,435 | 10,137 | 15,212 | 19,211 |
| Other Non-Current Liabilities | 57,011 | 58,179 | 59,140 | 52,674 | 53,832 |
| TOTAL | $81,078 | $86,386 | $91,462 | $89,267 | $91,198 |
| Total Liabilities | $119,650 | $117,865 | $121,282 | $122,418 | $126,316 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 52,974 | 52,863 | 47,882 | 47,825 | 47,819 |
| Common Shares | 6 | 5 | 5 | 5 | 5 |
| Retained earnings | -309,400 | -277,739 | -247,597 | -227,984 | -204,987 |
| TOTAL | $255,221 | $122,967 | $150,867 | $168,961 | $190,607 |
| Total Liabilities And Equity | $374,871 | $240,832 | $272,149 | $291,379 | $316,923 |